Suppr超能文献

药物洗脱冠状动脉支架的支架移位力:一项台架试验。

Stent dislodgement force of drug-eluting coronary stents: a bench test.

作者信息

Seo Kyoung-Woo, Yang Hyoung-Mo, Lim Hong-Seok, Yoon Myeong-Ho

机构信息

Department of Cardiology, Ajou University School of Medicine, Suwon, Republic of Korea.

出版信息

Cardiovasc Diagn Ther. 2022 Jun;12(3):370-377. doi: 10.21037/cdt-22-49.

Abstract

BACKGROUND

Coronary stent dislodgement can cause critical complications. The dislodgement force of coronary drug-eluting stents (DES) remains unknown. This study aimed to compare the dislodgement force and pattern of contemporary DES.

METHODS

Five DES designs which commonly used in clinical practice were tested. The force at which the stent dislodges relative to the balloon was measured. For the shim test, peak displacement force, defined as the first peak force that occurs during stent displacement and peak dislodgement force, defined as the peak force required to completely dislodge the stent from the delivery system, were measured. Three examples of each of the stents were tested using the shim test.

RESULTS

The peak displacement force of Orsiro (3.1±0.8 N) was lower than that of Xience Sierra (5.8±0.5 N) [Firehawk 3.8±0.2 N, Resolute Onyx 4.5±1.5 N, Synergy 4.8±0.5 N (P=0.024)]. The peak dislodgement force was lowest in Orsiro (3.2±0.8 N) when compared to the other stents (Firehawk 6.6±0.6 N, Resolute Onyx 7.4±0.3 N, Synergy 11.8±0.4 N, Xience Sierra 11.1±1.6 N) (P<0.001); this remained significant in the multiple comparison analysis. During pullback of the stents, most stents buckled without removal. However, the whole Orsiro stent was completely removed from the delivery system.

CONCLUSIONS

The dislodgement force of DESs differed between stent designs. The Orsiro stent was lower than that of other DES; additionally, it easily removed the whole stent from the delivery system. During the coronary intervention, operators should consider stent design and be cautious when pulling DES back in lesions with calcifications or a previously implanted stent, which are at high risk for stent dislodgement.

摘要

背景

冠状动脉支架移位可导致严重并发症。冠状动脉药物洗脱支架(DES)的移位力尚不清楚。本研究旨在比较当代DES的移位力和模式。

方法

测试了临床实践中常用的五种DES设计。测量支架相对于球囊移位时的力。对于垫片试验,测量峰值位移力(定义为支架移位过程中出现的第一个峰值力)和峰值移位力(定义为将支架从输送系统完全移位所需的峰值力)。每种支架取三个样本进行垫片试验。

结果

Orsiro支架的峰值位移力(3.1±0.8 N)低于Xience Sierra支架(5.8±0.5 N)[Firehawk支架为3.8±0.2 N,Resolute Onyx支架为4.5±1.5 N, Synergy支架为4.8±0.5 N(P=0.024)]。与其他支架相比,Orsiro支架的峰值移位力最低(3.2±0.8 N)(Firehawk支架为6.6±0.6 N,Resolute Onyx支架为7.4±0.3 N,Synergy支架为11.8±0.4 N,Xience Sierra支架为11.1±1.6 N)(P<0.001);在多重比较分析中,这一差异仍具有统计学意义。在支架回撤过程中,大多数支架发生弯曲但未被移除。然而,整个Orsiro支架完全从输送系统中移除。

结论

不同设计的DES移位力有所不同。Orsiro支架的移位力低于其他DES;此外,它能轻松地将整个支架从输送系统中移除。在冠状动脉介入治疗期间,操作者应考虑支架设计,并且在钙化病变或先前植入过支架(这些情况发生支架移位的风险较高)中回撤DES时要谨慎操作。

相似文献

引用本文的文献

本文引用的文献

9
Stent longitudinal integrity bench insights into a clinical problem.支架纵向完整性台架研究对临床问题的深入了解。
JACC Cardiovasc Interv. 2011 Dec;4(12):1310-7. doi: 10.1016/j.jcin.2011.11.002. Epub 2011 Nov 30.
10
Failure to retrieve undeployed paclitaxel-eluting coronary stents.未能取出未展开的紫杉醇洗脱冠状动脉支架。
Am J Cardiol. 2006 Feb 15;97(4):502-5. doi: 10.1016/j.amjcard.2005.09.085. Epub 2006 Jan 4.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验